Medtronic plc Equity Method Investment, Other than Temporary Impairment
Medtronic plc (MDT) reported Equity Method Investment, Other than Temporary Impairment of $1.00 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-03.
Financial Statements › Income Statement › Other Income
us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2026-09-03
- Medtronic plc equity method investment, other than temporary impairment for the quarter ending 2026-07-31 was $1.00M, a 96.15% decline year-over-year.
- Medtronic plc equity method investment, other than temporary impairment for the quarter ending 2026-04-24 was $9.00M, a 52.63% decline year-over-year.
- Medtronic plc equity method investment, other than temporary impairment for the quarter ending 2026-01-23 was $0.00, a 100.00% decline year-over-year.
- Medtronic plc equity method investment, other than temporary impairment for the quarter ending 2025-07-25 was $26.00M.
- Medtronic plc equity method investment, other than temporary impairment for fiscal 2026 was $71.00M, a 47.41% decline from fiscal 2025.
- Medtronic plc equity method investment, other than temporary impairment for fiscal 2025 was $135.00M.
| Period end | Equity Method Investment, Other than Temporary Impairment 3 month | Equity Method Investment, Other than Temporary Impairment 6 month | Equity Method Investment, Other than Temporary Impairment 9 month | Equity Method Investment, Other than Temporary Impairment 12 month |
|---|---|---|---|---|
| 2026-07-31 | $1.00M 10-Q · filed 2026-09-03 | $10.00M derived: sum of 2 quarters · filed 2026-09-03 | $10.00M derived: sum of 3 quarters · filed 2026-09-03 | |
| 2026-04-24 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $9.00M derived: sum of 2 quarters · filed 2026-06-18 | $71.00M 10-K · filed 2026-06-18 | |
| 2026-01-23 | $0.00 10-Q · filed 2026-02-24 | $62.00M 10-Q · filed 2026-02-24 | ||
| 2025-07-25 | $26.00M 10-Q · filed 2026-09-03 | $45.00M derived: sum of 2 quarters · filed 2026-09-03 | $116.00M derived: sum of 3 quarters · filed 2026-09-03 | |
| 2025-04-25 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $90.00M derived: sum of 2 quarters · filed 2026-06-18 | $135.00M 10-K · filed 2026-06-18 | |
| 2025-01-24 | $71.00M 10-Q · filed 2026-02-24 | $116.00M 10-Q · filed 2026-02-24 | ||
| 2024-01-26 | $0.00 10-Q · filed 2025-02-25 | $21.00M 10-Q · filed 2025-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B |